Get regular updates to your inbox.
Smaller particles and optimal inhalation speed of inhaler treatments — a mainstay for people with chronic obstructive pulmonary disease (COPD) — enhance their delivery to deep airway passages, a study shows. The study, “Computational evaluation of drug delivery in human respiratory tract under realistic inhalation,” was…
GoodRx, a platform for healthcare savings in the U.S., and pharmaceutical company Boehringer Ingelheim have teamed up to help lower out-of-pocket medication costs for people with chronic obstructive pulmonary disease (COPD) or type 2 diabetes. Patients will be able to enroll in sponsored copay programs to access Boehringer…
Treatment with mepolizumab, an antibody designed to lower the levels of eosinophils — immune cells linked with worse chronic obstructive pulmonary disease (COPD) — was found to reduce the annual rate of exacerbations and improve health-related quality of life in people with eosinophil-associated COPD. The findings, from a meta-analysis…
COPD SOS, a public service campaign spearheaded by veteran broadcast journalist Ted Koppel and his wife, is aimed at identifying the millions of people who don’t yet know that they have chronic obstructive pulmonary disease (COPD). This disease is estimated to affect 30 million people in the U.S.,…
Injecting mice with healthy lung endothelial cells — specialized cells lining the inside of blood vessels — prevented, and in some cases reversed, lung damage associated with emphysema, a severe form of chronic obstructive pulmonary disease (COPD), in a recent study. The study, “Reversal of emphysema…
The Zephyr Endobronchial Valve leads to sustained and significant improvements in lung function, exercise capacity, and quality of life in people with homogeneous emphysema, a severe form of chronic obstructive pulmonary disease (COPD), according to one-year data from the IMPACT clinical study. “This is very important data because…
Mice lacking a protein called FCHSD1 were protected from developing emphysema, a severe form of chronic obstructive pulmonary disease (COPD), according to data from a recent study. Based on these observations, researchers say this protein could serve as a future therapeutic target for COPD. “Our findings may also lead…
The Emphysema Foundation of America (EFA) — a nonprofit focused on raising awareness of chronic obstructive pulmonary disease (COPD) — is teaming up with the Olympus Corporation of the Americas, a medical device company, to provide free online workshops meant to educate COPD patients about lung health. These…
The COPD Foundation is partnering with Savana, a machine learning and artificial intelligence company, to develop a way of better identifying people with chronic obstructive pulmonary disease (COPD) who have not yet been diagnosed, or are at high risk of this disease. De-identified data in electronic medical…
Dental care in Brazil needs to be more accessible to patients with chronic obstructive pulmonary disease (COPD) and integrated into their primary care to better tackle the impact of the disease in the country, a study suggests. “Our research indicates that incorporating preventative oral health into COPD management and…
Get regular updates to your inbox.